콜플랜트 바이오테크놀로지 ADRCLGN 주가

12 Health Care Stocks Moving In Friday's After-Market Session

Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy

From mining to biotech, these companies are exploring strategic alternatives, including a sale, to unlock growth and value.

CollPlant Biotechnologies Q1 Adj. EPS $(0.21) Misses $(0.19) Estimate, Sales $73.000K Miss $1.100M Estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.19) by 10.53 percent. This is a 110 percent decrease over losses of $(0.10) per

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER

[3] 3

[EFFECT] EFFECT

[424B3] 424B3 — PROSPECTUS

[CORRESP] CORRESP

[F-1/A] F-1/A — PRE-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1

[6-K] 6-K — REPORT OF FOREIGN PRIVATE ISSUER